Literature DB >> 27432864

Renal Nerve Stimulation-Induced Blood Pressure Changes Predict Ambulatory Blood Pressure Response After Renal Denervation.

Mark R de Jong1, Ahmet Adiyaman1, Pim Gal1, Jaap Jan J Smit1, Peter Paul H M Delnoy1, Jan-Evert Heeg1, Boudewijn A A M van Hasselt1, Elizabeth O Y Lau1, Alexandre Persu1, Jan A Staessen1, Anand R Ramdat Misier1, Jonathan S Steinberg1, Arif Elvan2.   

Abstract

Blood pressure (BP) response to renal denervation (RDN) is highly variable and its effectiveness debated. A procedural end point for RDN may improve consistency of response. The objective of the current analysis was to look for the association between renal nerve stimulation (RNS)-induced BP increase before and after RDN and changes in ambulatory BP monitoring (ABPM) after RDN. Fourteen patients with drug-resistant hypertension referred for RDN were included. RNS was performed under general anesthesia at 4 sites in the right and left renal arteries, both before and immediately after RDN. RNS-induced BP changes were monitored and correlated to changes in ambulatory BP at a follow-up of 3 to 6 months after RDN. RNS resulted in a systolic BP increase of 50±27 mm Hg before RDN and systolic BP increase of 13±16 mm Hg after RDN (P<0.001). Average systolic ABPM was 153±11 mm Hg before RDN and decreased to 137±10 mm Hg at 3- to 6-month follow-up (P=0.003). Changes in RNS-induced BP increase before versus immediately after RDN and changes in ABPM before versus 3 to 6 months after RDN were correlated, both for systolic BP (R=0.77, P=0.001) and diastolic BP (R=0.79, P=0.001). RNS-induced maximum BP increase before RDN had a correlation of R=0.61 (P=0.020) for systolic and R=0.71 (P=0.004) for diastolic ABPM changes. RNS-induced BP changes before versus after RDN were correlated with changes in 24-hour ABPM 3 to 6 months after RDN. RNS should be tested as an acute end point to assess the efficacy of RDN and predict BP response to RDN.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  24-hour ABPM; drug-resistant hypertension; renal denervation; renal nerve stimulation

Mesh:

Year:  2016        PMID: 27432864     DOI: 10.1161/HYPERTENSIONAHA.116.07492

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Changes in arterial pressure hemodynamics in response to renal nerve stimulation both before and after renal denervation.

Authors:  Annemiek F Hoogerwaard; Ahmet Adiyaman; Mark R de Jong; Jaap Jan J Smit; Peter Paul H M Delnoy; Jan-Evert Heeg; Boudewijn A A M van Hasselt; Anand R Ramdat Misier; Michiel Rienstra; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2018-05-29       Impact factor: 5.460

Review 2.  Modulation of renal sympathetic innervation: recent insights beyond blood pressure control.

Authors:  Dominik Linz; Mathias Hohl; Adrian D Elliott; Dennis H Lau; Felix Mahfoud; Murray D Esler; Prashanthan Sanders; Michael Böhm
Journal:  Clin Auton Res       Date:  2018-02-10       Impact factor: 4.435

3.  Selective renal denervation guided by renal nerve stimulation: mapping renal nerves for unmet clinical needs.

Authors:  Kunyue Tan; Yinchuan Lai; Weijie Chen; Hang Liu; Yanping Xu; Yidan Li; Hao Zhou; Wenxin Song; Jie Wang; Kamsang Woo; Yuehui Yin
Journal:  J Hum Hypertens       Date:  2019-09-02       Impact factor: 3.012

Review 4.  Selective vs. Global Renal Denervation: a Case for Less Is More.

Authors:  Marat Fudim; Asher A Sobotka; Yue-Hui Yin; Joanne W Wang; Howard Levin; Murray Esler; Jie Wang; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

Review 5.  Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation.

Authors:  John W Osborn; Christopher T Banek
Journal:  Hypertension       Date:  2018-01-02       Impact factor: 10.190

6.  Effects of renal sympathetic denervation on the stellate ganglion and brain stem in dogs.

Authors:  Wei-Chung Tsai; Yi-Hsin Chan; Kroekkiat Chinda; Zhenhui Chen; Jheel Patel; Changyu Shen; Ye Zhao; Zhaolei Jiang; Yuan Yuan; Michael Ye; Lan S Chen; Amanda A Riley; Scott A Persohn; Paul R Territo; Thomas H Everett; Shien-Fong Lin; Harry V Vinters; Michael C Fishbein; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2016-10-05       Impact factor: 6.343

Review 7.  Device-based therapies for arterial hypertension.

Authors:  Lucas Lauder; Michel Azizi; Ajay J Kirtane; Michael Böhm; Felix Mahfoud
Journal:  Nat Rev Cardiol       Date:  2020-04-14       Impact factor: 32.419

Review 8.  Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.

Authors:  Annemiek F Hoogerwaard; Mark R de Jong; Arif Elvan
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

Review 9.  ConfidenHT™ System for Diagnostic Mapping of Renal Nerves.

Authors:  Costas Tsioufis; Kyriakos Dimitriadis; Panagiotis Tsioufis; Rafael Patras; Maria Papadoliopoulou; Zoi Petropoulou; Dimitris Konstantinidis; Dimitrios Tousoulis
Journal:  Curr Hypertens Rep       Date:  2018-05-19       Impact factor: 5.369

10.  Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.

Authors:  Mark R de Jong; Annemiek F Hoogerwaard; Ahmet Adiyaman; Jaap Jan J Smit; Anand R Ramdat Misier; Jan-Evert Heeg; Boudewijn A A M van Hasselt; Isabelle C Van Gelder; Harry J G M Crijns; Ignacio Fernández Lozano; Jorge E Toquero Ramos; F Javier Alzueta; Borja Ibañez; José M Rubio; Fernando Arribas; José M Porres Aracama; Josep Brugada; Lluís Mont; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2018-02-27       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.